Goldman Sachs Future Health Care Equity ETF(GDOC)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
2-STAR RATING
PASS
LAST CLOSE
$36.55
10/14/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for GDOC

10/14/2026: GDOC (2-star) is currently NOT-A-BUY. Pass it for now.

GDOC provides targeted exposure to companies driving future innovation in the health care industry through an active management approach. Its main strengths include the high-caliber research capabilities of Goldman Sachs and a focus on high-growth areas like biotech. It is best used as a satellite position in a diversified growth portfolio. The primary risks involve sector-specific regulatory volatility and the inherent uncertainty of clinical and technological outcomes. The fund is most suitable for long-term investors capable of tolerating above-average volatility in exchange for potential growth.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.

Investor Fit

Investor styleFitWhy
Growth investorStrong fitThe fund targets companies at the forefront of medical innovation, aligning well with growth-oriented mandates.
Momentum investorStrong fit while signal remains positiveThematic health care can experience strong upward momentum during market cycles favoring innovation.
Value investorWeak fitThe fund focuses on future growth and innovation rather than current earnings or low price-to-book ratios.
Dividend/Income investorWeak fitInnovation-focused health care companies rarely prioritize dividend payouts.
Low-risk investorWeak fitThe thematic focus and active management carry higher volatility than broad-market health care funds.

Investor Profile

Ideal Investor Profile

The ideal investor is a long-term growth seeker with a high risk tolerance and a focus on secular health care trends.

Suitability

GDOC is best suited for long-term investors looking to complement a core, diversified portfolio with specialized health care innovation exposure.

Risk Profile

Risk factorLevelWhy it matters
VolatilityHighThe focus on innovation leads to significant price fluctuations based on regulatory or clinical data.
Market riskMedium / highBroader market downturns typically impact high-multiple growth equities aggressively.
ConcentrationMedium / highBeing restricted to the health care sector exposes the fund to industry-specific regulatory risks.
Tracking/expenseMediumThe 0.59% expense ratio is higher than passive sector index alternatives.
LiquidityMediumLower average daily volume compared to major sector ETFs may affect execution during market volatility.
Business/sector qualityMediumReliance on specific scientific advancements makes the portfolio susceptible to single-company failures.

Risk Analysis

Volatility

GDOC exhibits higher volatility than broad health care ETFs due to its concentration in growth-oriented, innovative firms.

Market Risk

The fund is subject to significant market risk, particularly sensitive to interest rate fluctuations and regulatory announcements affecting its core holdings.

What the ETF Owns

Exposure TypeExposureWeight (%)Retail Investor Read
SectorHealth Care Equities92The vast majority of the fund is invested in health care companies driving innovation.
IndustryBiotechnology and Life Sciences5This small allocation provides liquidity and defensive backing to the portfolio.
Cash/collateralCash and Cash Equivalents3Cash balances are held for liquidity and operational purposes.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Smooth
PRICE STABILITY

Smooth

The stock has moved along a generally orderly path with only modest fluctuations.

Analysis of Past Performance

Type ETF
Historic Profit 11.54%
Avg. Invested days 47
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
ETF Returns Performance Upturn Returns Performance icon 3.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 10/14/2026
Advertisement
Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.